Immune–proteo–metabolomic changes link to Aβ and tau pathology in Alzheimer disease
Meng Wang(Max Delbrück Center), Chotima Böttcher(Berlin-Brandenburger Centrum für Regenerative Therapien), Helena Radbruch(Charité - Universitätsmedizin Berlin), Jenny Meinhardt(Humboldt-Universität zu Berlin), P J Oefner(University of Regensburg), Camila Fernández‐Zapata(Max Delbrück Center), Claudia Samol(University of Regensburg), Gerardina Gallaccio(Max Delbrück Center), Klemens Ruprecht(Charité - Universitätsmedizin Berlin), Maria Buthut(Einstein Center for Neurosciences Berlin), Simon Heckscher(University of Regensburg), Carolin Otto(Humboldt-Universität zu Berlin), Christian Conrad(Humboldt-Universität zu Berlin), Sakshi Kamboj(University of Regensburg), Matteo Teves(University of Regensburg), Harald Prüß(German Center for Neurodegenerative Diseases), Katja Dettmer(University of Regensburg), Yozlem Bahar(Max Delbrück Center), Friedemann Paul(Max Delbrück Center), Wolfram Gronwald(University of Regensburg), Christian Böttcher(Max Delbrück Center), Désirée Kunkel(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)
Cited by 1
Related Papers
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
|Nature Neuroscience|2020|1.5k
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
|Journal of Neuroinflammation|2016|896
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740
A blood based 12-miRNA signature of Alzheimer disease patients
|Genome biology|2013|514